Related Experiment Video
Updated: May 27, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Stabilizing microtubules decreases myocardial ischaemia-reperfusion injury
1Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu Province, China.
Abstract:
Microtubules are important components of the cytoskeleton that forms the backbone of myocardial architecture, sustaining its form and size. This study investigated whether stabilizing microtubules with paclitaxel (0.1 or 1 μM) could decrease myocardial ischaemia- reperfusion injury, and reduce myocardial infarct size and the incidence of ischaemic ventricular arrhythmia. Isolated rat hearts were used, with arrhythmia induced by regional ischaemia and myocardial infarcts induced by ischaemia-reperfusion. In these ex vivo rat models, paclitaxel decreased myocardial ischaemia-reperfusion injury, significantly reducing the incidence and severity of ischaemic ventricular arrhythmia and significantly decreasing infarct size.
Insights
Stabilizing microtubules with paclitaxel reduced heart injury from ischemia-reperfusion. This treatment significantly decreased infarct size and the occurrence of ventricular arrhythmias in isolated rat hearts.
Area of Science:
- Cardiovascular Science
- Cell Biology
- Pharmacology
Background:
- Microtubules are crucial cytoskeletal elements maintaining myocardial architecture.
- Myocardial ischemia-reperfusion injury is a significant clinical concern.
- Ventricular arrhythmias and infarct expansion are severe consequences of ischemia-reperfusion.
Purpose of the Study:
- To investigate the protective effects of paclitaxel, a microtubule-stabilizing agent, against myocardial ischemia-reperfusion injury.
- To determine if paclitaxel can reduce infarct size and the incidence of ischemic ventricular arrhythmias.
Main Methods:
- Isolated rat hearts were subjected to regional ischemia followed by reperfusion.
- Myocardial infarcts and ventricular arrhythmias were induced using established ex vivo protocols.
- Paclitaxel was administered at concentrations of 0.1 μM and 1 μM.
Main Results:
- Paclitaxel administration significantly decreased myocardial ischemia-reperfusion injury.
- Treatment with paclitaxel led to a significant reduction in both the incidence and severity of ischemic ventricular arrhythmias.
- A significant decrease in myocardial infarct size was observed in paclitaxel-treated hearts.
Conclusions:
- Stabilization of microtubules with paclitaxel confers significant protection against myocardial ischemia-reperfusion injury.
- Paclitaxel demonstrates therapeutic potential in mitigating arrhythmias and reducing infarct size in ischemic heart conditions.
- Targeting the microtubule cytoskeleton may represent a novel therapeutic strategy for managing cardiac ischemia.
Related Concept Videos
Drugs that Stabilize Microtubules
Destabilization of Microtubules
Microtubule Instability
Drugs that Destabilize Microtubules

